NASDAQ:MDXH

MDxHealth (MDXH) Stock Forecast, Price & News

$3.64

+0.05 (+1.39%)

(As of 05/31/2023 ET)

Compare

Today's Range: $3.54
▼
$3.77
50-Day Range: $2.85
▼
$4.20
52-Week Range: $2.47
▼
$9.49

Volume: 140,849 shs
Average Volume: 234,163 shs
Market Capitalization: $59.30 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $11.67

MDxHealth MarketRank™ Forecast

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 188.5% Upside
$10.50 Price Target
Short Interest: Healthy
0.51% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($1.40) to ($1.13) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.14 out of 5 stars

Medical Sector

472nd out of 1,006 stocks

Medical Laboratories Industry

12th out of 24 stocks

3.5

Analyst's Opinion

Consensus Rating
MDxHealth has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $10.50, MDxHealth has a forecasted upside of 188.5% from its current price of $3.64.
Amount of Analyst Coverage
MDxHealth has only been the subject of 3 research reports in the past 90 days.

5.0

Short Interest

Percentage of Shares Shorted
0.51% of the float of MDxHealth has been sold short.
Short Interest Ratio / Days to Cover
MDxHealth has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in MDxHealth has recently decreased by 6.50%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
MDxHealth does not currently pay a dividend.
Dividend Growth
MDxHealth does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for MDXH.

2.5

News and Social Media Coverage

News Sentiment
MDxHealth has a news sentiment score of 1.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.79 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 1 news article for MDxHealth this week, compared to 2 articles on an average week.
Search Interest
Only 14 people have searched for MDXH on MarketBeat in the last 30 days. This is a decrease of -13% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, MDxHealth insiders have not sold or bought any company stock.
Percentage Held by Institutions
Only 12.56% of the stock of MDxHealth is held by institutions.

0.6

Earnings and Valuation

Earnings Growth
Earnings for MDxHealth are expected to grow in the coming year, from ($1.40) to ($1.13) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of MDxHealth is -1.92, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of MDxHealth is -1.92, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
MDxHealth has a P/B Ratio of 1.58. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About MDxHealth (NASDAQ:MDXH) Stock

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.

Receive MDXH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MDxHealth and its competitors with MarketBeat's FREE daily newsletter.

MDXH Stock News Headlines

May 23, 2023 | finance.yahoo.com

MDxHealth to Present at the 43rd Annual William Blair Growth Stock Conference

May 16, 2023 | marketwatch.com

2030, Oncology Precision Medicine Market Research

June 1, 2023 | Vantage Point (Ad)

We Called (ARWR) In Advance, Which Stocks Are Next?

Nearly 56% gains in 30 days! This bullish trend reversal was not only forecasted by A.I., but we called it 1 – 3 days in advance. If you have any money invested in the markets…even just your retirement, you’ll want to see this. Plus, it’s FREE - the training is only an hour & LIVE.

May 16, 2023 | msn.com

BTIG Maintains Buy Rating for MDxHealth: Here's What You Need To Know

May 16, 2023 | americanbankingnews.com

BTIG Research Trims MDxHealth (NASDAQ:MDXH) Target Price to $7.00

May 16, 2023 | finanznachrichten.de

mdxhealth: MDxHealth Reports Q1-2023 Results

May 16, 2023 | markets.businessinsider.com

BTIG Reaffirms Their Buy Rating on MDxHealth S.A. Sponsored ADR (MDXH)

May 16, 2023 | americanbankingnews.com

Financial Survey: MDxHealth (NASDAQ:MDXH) vs. First Choice Healthcare Solutions (OTCMKTS:FCHS)

June 1, 2023 | Vantage Point (Ad)

We Called (ARWR) In Advance, Which Stocks Are Next?

May 15, 2023 | finance.yahoo.com

MDxHealth SA Sponsored ADR (MDXH) Reports Q1 Loss, Tops Revenue Estimates

May 15, 2023 | finance.yahoo.com

MDxHealth Reports Q1-2023 Results

May 14, 2023 | markets.businessinsider.com

MDxHealth earnings preview: what Wall Street is expecting

May 12, 2023 | marketwatch.com

Globally Liquid Biopsy Products Market Growth Rate 2023

May 12, 2023 | msn.com

MDxHealth (EBR:MDXH) Price Target Decreased by 85.83% to 1.26

May 3, 2023 | americanbankingnews.com

Head to Head Analysis: HH&L Acquisition (NYSE:HHLA) and MDxHealth (NASDAQ:MDXH)

May 1, 2023 | finance.yahoo.com

MDxHealth to Present First Quarter 2023 Financial Results on May 15

April 28, 2023 | marketwatch.com

Global Liquid Biopsy Market by [2023-2029] with Revenue Outsourcing

April 25, 2023 | msn.com

Short Volatility Alert: Mdxhealth

April 24, 2023 | marketwatch.com

2023, The Metabolomic Platform Market is Expected to Witness a Substantial Rise in Revenue

April 19, 2023 | finance.yahoo.com

Foundational LCD Covers Select mdx for Prostate Cancer

April 19, 2023 | finance.yahoo.com

Earnings Preview: MDxHealth SA Sponsored ADR (MDXH) Q1 Earnings Expected to Decline

April 13, 2023 | americanbankingnews.com

Contrasting MDxHealth (MDXH) and Its Competitors

April 11, 2023 | americanbankingnews.com

Contrasting MDxHealth (MDXH) & Its Competitors

April 10, 2023 | americanbankingnews.com

Head to Head Analysis: MDxHealth (MDXH) vs. The Competition

April 8, 2023 | americanbankingnews.com

Critical Analysis: MDxHealth (MDXH) & Its Rivals

April 6, 2023 | americanbankingnews.com

MDxHealth (MDXH) & Its Rivals Head to Head Survey

April 5, 2023 | americanbankingnews.com

Contrasting MDxHealth (MDXH) and The Competition

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive MDXH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MDxHealth and its competitors with MarketBeat's FREE daily newsletter.

MDXH Company Calendar

Last Earnings: 3/08/2023
Today: 5/31/2023
Next Earnings (Estimated): 8/24/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Medical laboratories
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:MDXH
CUSIP: N/A
CIK: 1872529
Web: mdxhealth.com
Phone: 324-364-2070
Fax: N/A
Employees: N/A
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $10.50
High Stock Price Forecast: $18.00
Low Stock Price Forecast: $7.00
Forecasted Upside/Downside: +220.5%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 5 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.90)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-44,040,000.00
Net Margins: -104.02%
Pretax Margin: -118.86%
Return on Equity: -193.40%
Return on Assets: -42.11%

Debt

Debt-to-Equity Ratio: 1.00
Current Ratio: 3.27
Quick Ratio: 3.16

Sales & Book Value

Annual Sales: $37.05 million
Price / Sales: 1.60
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $2.31 per share
Price / Book: 1.58

Miscellaneous

Outstanding Shares: 16,290,000
Free Float: N/A
Market Cap: $59.30 million
Optionable: Not Optionable
Beta: 0.24

Key Executives

Mr. Michael K. McGarrity (Age 59)
CEO & Exec. Director
Comp: $502.44k

Mr. Ron Kalfus (Age 48)
Chief Financial Officer

Mr. Joseph Sollee (Age 57)
Exec. VP of Corp. Devel. & Gen. Counsel

Mr. John A. Bellano (Age 53)
Chief Commercial Officer

Ms. Miriam Reyes (Age 49)
Exec. VP of Operations

Dr. Wim Van Criekinge (Age 50)
Chief Scientific Officer

Mr. Paul Marr
Exec. VP of Sales for North America

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

MDXH Stock - Frequently Asked Questions

Should I buy or sell MDxHealth stock right now?: 5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for MDxHealth in the last twelve months. There are currently 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" MDXH shares.
View MDXH analyst ratings or view top-rated stocks.
What is MDxHealth's stock price forecast for 2023?: 5 equities research analysts have issued 1-year target prices for MDxHealth's shares. Their MDXH share price forecasts range from $7.00 to $18.00. On average, they predict the company's share price to reach $10.50 in the next year. This suggests a possible upside of 188.5% from the stock's current price.
View analysts price targets for MDXH or view top-rated stocks among Wall Street analysts.
How have MDXH shares performed in 2023?: MDxHealth's stock was trading at $6.61 at the beginning of the year. Since then, MDXH stock has decreased by 44.9% and is now trading at $3.64.
View the best growth stocks for 2023 here.
When is MDxHealth's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, August 24th 2023.
View our MDXH earnings forecast.
How were MDxHealth's earnings last quarter?: MDxHealth SA (NASDAQ:MDXH) posted its quarterly earnings results on Wednesday, March, 8th. The company reported ($1.10) earnings per share for the quarter, missing analysts' consensus estimates of ($0.75) by $0.35. The company had revenue of $12.89 million for the quarter, compared to analyst estimates of $14.76 million. MDxHealth had a negative trailing twelve-month return on equity of 193.40% and a negative net margin of 104.02%.
When did MDxHealth IPO?: (MDXH) raised $45 million in an initial public offering on Thursday, November 4th 2021. The company issued 3,750,000 shares at a price of $12.00 per share.

What is MDxHealth's stock symbol?: MDxHealth trades on the NASDAQ under the ticker symbol "MDXH."
Who are MDxHealth's major shareholders?: MDxHealth's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Alyeska Investment Group L.P. (3.68%), Hood River Capital Management LLC (3.55%), Ally Bridge Group NY LLC (3.07%), Element Capital Management LLC (2.63%), Perkins Capital Management Inc. (2.51%) and Sei Investments Co. (1.03%).
View institutional ownership trends.
How do I buy shares of MDxHealth?: Shares of MDXH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is MDxHealth's stock price today?: One share of MDXH stock can currently be purchased for approximately $3.64.
How much money does MDxHealth make?: MDxHealth (NASDAQ:MDXH) has a market capitalization of $59.30 million and generates $37.05 million in revenue each year. The company earns $-44,040,000.00 in net income (profit) each year or ($1.90) on an earnings per share basis.
How can I contact MDxHealth?: MDxHealth's mailing address is CAP Business Center, Herstal, Liege 4040. The official website for the company is mdxhealth.com. The company can be reached via phone at 324-364-2070 or via email at ir@mdxhealth.com.

This page (NASDAQ:MDXH) was last updated on 6/1/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial